ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA The prevalence...

6
ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA The prevalence of antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus is rapidly increasing in healthcare facilities and spreading to the community. Methicillin-resistant S. aureus colonize the skin and open wounds and can interfere with wound healing. Recent studies have shown that ultraviolet light C can kill antibiotic-resistant strains of bacteria such as methicillin-resistant S. aureus in both laboratory cultures and animal tissue. This clinical report describes the effects of ultraviolet light C on wound bioburden and closure in people with chronic ulcers infected with methicillin-resistant S. aureus.. This case studies also suggests that ultraviolet light C is a promising adjunctive therapy for chronic wounds containing antibiotic-resistant bacteria such as methicillin-resistant S. THE TREATMENT

Transcript of ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA The prevalence...

Page 1: ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA The prevalence of antibiotic-resistant bacteria such as methicillin-resistant.

ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA

  The prevalence of antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus is rapidly increasing in healthcare facilities and spreading to the community. Methicillin-resistant S. aureus colonize the skin and open wounds and can interfere with wound healing. Recent studies have shown that ultraviolet light C can kill antibiotic-resistant strains of bacteria such as methicillin-resistant S. aureus in both laboratory cultures and animal tissue. This clinical report describes the effects of ultraviolet light C on wound bioburden and closure in people with chronic ulcers infected with methicillin-resistant S. aureus.. This case studies also suggests that ultraviolet light C is a promising adjunctive therapy for chronic wounds containing antibiotic-resistant bacteria such as methicillin-resistant S. aureus.

THE TREATMENT

Page 2: ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA The prevalence of antibiotic-resistant bacteria such as methicillin-resistant.

Create a bacteria-free environment to treat Decubitus ulcers.

Create an environment to enhance the healing and prevent future infection.

Sanitize linens and other material coming in contact with the wound.

Destroy pathogens rather than permitting mutation to more difficult drug resistant bacteria.

The SM2020 has proven to be 99.9% kill rate effective for the methicillin-resistant strain of S. aureus (MRSA) after 90 seconds treatment. The kill rate reaches 100% effectiveness after 180 seconds.

For vancomycin resistant E. faecalis (VRE) the SM2020 was 99.9% effective at 45 seconds and 100% effective @ 90 seconds.

KEY POINTS

Page 3: ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA The prevalence of antibiotic-resistant bacteria such as methicillin-resistant.

SM2020 – CUSTOMIZED MEDICAL GERMICIDAL ULTRAVIOLET SANITIZING SYSTEM

UVC TREATMENT PROTOCOLUsing an application technique that has been prescribed by Nussbaum et.al, our UVmax SM2020 UVC is applied at a distance of 9” vertically above the wound using pre measured and customized fittings. Before treatment, the customized UVmax SM2020 with a 253.7 nm hot cathode UVC double tube lamps and generator is warmed up for 5 minutes before being placed above the wound. The ulcer is to be cleaned with sterile saline, and a layer of petroleum jelly is applied to the surrounding periulcer skin and any healthy granulation tissue. The wound edges are to be covered with a drape.

The UVmax SM2020 sanitizing system then is placed above the wound at 180 sec per wound site at a distance of 9”. This length of time is recommended for the treatment of infected ulcers and was selected based on MRSA killing rates reported in the in vitro study.Subsequent and further periodic treatment is based on the recommendation of the physician or specialist in attendance.

THE EQUIPMENT

Page 4: ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA The prevalence of antibiotic-resistant bacteria such as methicillin-resistant.

  Product Specifications

Filter HEPA

Negative Ion Generation rate 5 x 106 ions / cm3 (Effective hydroxyls purifies the surrounding air while simultaneously treating the infected area of the wound.)

Ultraviolet light With Intensity 30,000 µW /sec/cm2 enough for instant kill effect. Dual “H“-style lamps. Dual 18W, 9” length hot cathode ultraviolet double tube lamps.

Ozone application Optional (<0.04ppm)

Purification rate ≥ 99.965%

Anti-bacteria rate ≥ 90%

Thermal Heat Dissipation Prevents lamp cycling or premature failure.

Power supply 220 - 240V, 50Hz (< 30W) adjusts to voltage automatically

Dimension 320 x 170 x 300 mm

Safety Advanced end of life circuitry safely removes power from UVC lamps

Approval All Parts are CE, GS Approved

THE SPECIFICATION

Page 5: ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA The prevalence of antibiotic-resistant bacteria such as methicillin-resistant.

Changes in bacterial colonization of lower leg wound

0

1

2

3

Before UVC Treatment After single UVCtreatment

After 2 weeks UVCtreatment

After one month UVCtreatment

Treatment

Sem

iqu

anti

tati

ve s

wab

res

ult

s

MRSA Pseudomonas Staph Aureus

TREATMENT RESULTS

Page 6: ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA The prevalence of antibiotic-resistant bacteria such as methicillin-resistant.

SOMA Medical Sdn Bhd (671166-M)No. 2-4-2, 4th Floor Menara KLH Business

Centre2nd Mile Off Jalan Ipoh 51200 Kuala Lumpur

West MalaysiaTel: 603-2381 0581 / 0553

Fax: 603-2381 0351

Email: [email protected]: www.somamedical.net

SOMA Medical Sdn Bhd (671166-M)No. 2-4-2, 4th Floor Menara KLH Business

Centre2nd Mile Off Jalan Ipoh 51200 Kuala Lumpur

West MalaysiaTel: 603-2381 0581 / 0553

Fax: 603-2381 0351

Email: [email protected]: www.somamedical.net

Thank YouThank You